Acrivon Therapeutics
ACRV
ACRV
54 hedge funds and large institutions have $136M invested in Acrivon Therapeutics in 2024 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 6 reducing their positions, and 5 closing their positions.
Holders
54
Holders Change
+6
Holders Change %
+12.5%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
11
Increased
25
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AB
51
Amalgamated Bank
New York
| $2K | 378 | – | – |
|
52
Millennium Management
New York
| – | – | -95,497 | Closed |
|
|
PCM
53
Prelude Capital Management
New York
| – | – | -13,000 | Closed |
|
|
RJA
54
Raymond James & Associates
St Petersburg,
Florida
| – | – | -10,200 | Closed |
|
|
AIG
55
American International Group
New York
| – | – | -6,016 | Closed |
|
|
CFM
56
Catalyst Funds Management
Sydney NSW,
Australia
| – | – | -1,044 | Closed |
|
|
CAL
57
Capital Advisors Ltd
Shaker Heights,
Ohio
| $0 | 48 | – | – |
|
|
AW
58
Avion Wealth
The Woodlands,
Texas
| $0 | 88 | – | – |
|
|
CFGS
59
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
60
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $0 | 23 | +20 | +667% |
|